Compare Amplitude Inc (AMPL) vs Ascendis Pharma A/S (ASND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amplitude Inc vs Ascendis Pharma A/S — how do they compare? Amplitude Inc trades at $12.78 (market cap $1.59B), while Ascendis Pharma A/S trades at $254.5 (market cap $16.67B). The key difference: Ascendis Pharma A/S is far larger — about 10.5× Amplitude Inc's market cap, and Amplitude Inc is trading nearer its 52-week high, Ascendis Pharma A/S nearer its low. Which is the better fit depends on your goals.
| AMPL | ASND | |
|---|---|---|
Market Cap | $1.59B | $16.67B |
Sector | Technology | Health |
52-Week High | $12.69 | $277.18 |
52-Week Low | $5.61 | $189.74 |
Enterprise Value | $1.45B | $17.04B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amplitude Inc
Amplitude Inc is pioneering a new category of software called digital optimization. The company's digital optimization system serves as the command center for businesses to connect digital products to business outcomes.
Read more on AMPL →About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →
